Baseline Characteristic Of Participants In The Victor (Vericiguat Global Study In Participants With Chronic Heart Failure) Trial Global Study In Participants With Chronic Heart Failure) Trial:
Year: 2025
Type: article
Source: Journal of Cardiac Failure
Authors: Faiez Zannad, Ciaran McMullan, Davis Gates, Aiwen Xing, Kevin Anstrom, Marc Bonaca, Stefano Corda, Justin Ezekowitz, Carolyn Lam, Eldrin Lewis, JoAnn Lindenfeld, Robert Mentz, Christopher O'Connor, Mahesh Patel, Piotr Ponikowski, Yogesh Reddy, Giuseppe Rosano, Clara Ines Saldarriage-Giraldo, Michele Senni, James Udelson, Adriaan Voors, Javed Butler
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Bayer (Germany), Stanford Health Care, Stanford University, Vanderbilt University, Vanderbilt University Medical Center, Duke University, Duke University Health System, Inova Health System, Mayo Clinic, Tufts Medical Center, University of Mississippi, Baylor Scott & White Research Institute
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4406375570